ÀÏÀÚ ÆÄÀÏ Á¦¸ñ ±â°ü¸í
05-15    ¹Ì±¹ ¸¶°¨½ÃȲ : ¹ÌÁß Á¤»óȸ´ã ±â´ë°¨¿¡ »ó½Â¼¼ ¿¬Àå »ï¼ºÁõ±Ç
05-15    [JYP Ent. (035900)] ÁøÈ­ÇÏ´Â MD Àü·«, Ä¿Áö´Â ¼öÀÍ ±âȸ »ï¼ºÁõ±Ç
05-15    [»ï¼º»ý¸í (032830)] 1Q review - ÅõÀÚ ºÎ¹® ȯÀÔ ¿äÀÎÀ¸·Î ¼­ÇÁ.. »ï¼ºÁõ±Ç
05-15    [Kbank (279570)] Core growth masked by excessive concerns »ï¼ºÁõ±Ç
05-15    [½Ã½ºÄÚ ½Ã½ºÅÛÁî (NAS:CSCO)] ¸ð¸àÅÒ¿¡ ºÒÀÌ ºÙ´Ù »ï¼ºÁõ±Ç
05-15    [ETFact Check] ¿¡³ÊÁö ¾Èº¸ ÆÐ·¯´ÙÀÓ, Àç»ý¿¡³ÊÁö ETF¿¡ ÁÖ¸ñ »ï¼ºÁõ±Ç
05-15    [¿µ¿ø¹«¿ª (111770)] ½ÇÀû¡¤¼öÁÖ¡¤¹ë·ù ¸ðµÎ ±àÁ¤Àû È帧 Áö¼Ó »ï¼ºÁõ±Ç
05-15    [¾ÈµÎ¸± (Anduril Industries, ¹Ì±¹ ºñ»óÀå)] Flame of the West.. »ï¼ºÁõ±Ç
05-15    [TES (095610)] Earnings strength supports valuation »ï¼ºÁõ±Ç
05-15    [Çѱ¹Àü·Â (015760)] 1Q review-´Ù¼Ò ¾Æ½¬¿ï »Ó ½Ç¸Á½º·´Áö ¾ÊÀº.. »ï¼ºÁõ±Ç
05-15    [Dentium (145720)] Beats consensus by optimizing costs »ï¼ºÁõ±Ç
05-15    [Classys (214150)] Fundamentals to normalize in 2Q »ï¼ºÁõ±Ç
05-15    [PharmaResearch (214450)] Moderate growth to lead to reratin.. »ï¼ºÁõ±Ç
05-15    [E-Mart (139480)] Core business¡¯s fundamentals improving »ï¼ºÁõ±Ç
05-15    [Seers (458870)] Operating margin tops 40% again »ï¼ºÁõ±Ç
Àüü : 93  Ã³À½     ÀÌÀü    [1] [2] [3] [4] [5]    ´ÙÀ½    ³¡À¸·Î 

Ȩ > ¸®¼­Ä¡Á¤º¸ > ÃֱٰԽù°